Effect of Whey and Albumin Protein on Plasma Levels of Amino Acids
1 other identifier
interventional
8
1 country
1
Brief Summary
The purpose of this study will allow us to examine how quickly and to what extent plasma amino acids levels rise after ingesting a single dose of either whey or albumin protein. The investigators anticipate that the amino acids from albumin concentrate protein will rise as quickly and to the same extent as amino acids from whey protein. These findings will help us to understand the biological availability of these proteins and efficacy of the supplement so that consumers may be presented with nutritional options.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2012
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2012
CompletedFirst Submitted
Initial submission to the registry
July 16, 2012
CompletedFirst Posted
Study publicly available on registry
July 18, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2012
CompletedFebruary 15, 2013
February 1, 2013
1 month
July 16, 2012
February 13, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
Amino acid concentration
210 minutes
Study Arms (2)
Whey Milk Protein
ACTIVE COMPARATORBovine Albumin Concentrate
EXPERIMENTALInterventions
20 grams of Bovine Albumin Concentrate
Eligibility Criteria
You may qualify if:
- normal Healthy volunteers
- free of serious illness/disease such as hypertension, kidney or liver disease
You may not qualify if:
- taking dietary protein or amino acid supplements
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Iowa State University
Ames, Iowa, 50011, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Rick Sharp, PhD
Iowa State University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 16, 2012
First Posted
July 18, 2012
Study Start
July 1, 2012
Primary Completion
August 1, 2012
Study Completion
September 1, 2012
Last Updated
February 15, 2013
Record last verified: 2013-02